AngioDynamics (NASDAQ:ANGO – Get Rating) and Ra Medical Systems (NYSE:RMED – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk and institutional ownership.
Risk and Volatility
AngioDynamics has a beta of 0.88, suggesting that its share price is 12% less volatile than the S&P 500. Comparatively, Ra Medical Systems has a beta of 1.57, suggesting that its share price is 57% more volatile than the S&P 500.
This table compares AngioDynamics and Ra Medical Systems’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Ra Medical Systems||-1,175.34%||-168.49%||-117.70%|
This is a summary of recent ratings and recommmendations for AngioDynamics and Ra Medical Systems, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Ra Medical Systems||0||0||1||0||3.00|
AngioDynamics currently has a consensus price target of $36.00, suggesting a potential upside of 92.62%. Ra Medical Systems has a consensus price target of $12.00, suggesting a potential upside of 4,232.13%. Given Ra Medical Systems’ higher probable upside, analysts clearly believe Ra Medical Systems is more favorable than AngioDynamics.
Earnings & Valuation
This table compares AngioDynamics and Ra Medical Systems’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|AngioDynamics||$291.01 million||2.49||-$31.55 million||($1.03)||-18.15|
|Ra Medical Systems||$20,000.00||447.49||-$25.07 million||($5.66)||-0.05|
Ra Medical Systems has lower revenue, but higher earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Ra Medical Systems, indicating that it is currently the more affordable of the two stocks.
Insider and Institutional Ownership
93.9% of AngioDynamics shares are held by institutional investors. Comparatively, 2.8% of Ra Medical Systems shares are held by institutional investors. 4.8% of AngioDynamics shares are held by company insiders. Comparatively, 12.3% of Ra Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
About AngioDynamics (Get Rating)
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon’s, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides vascular interventions and therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
About Ra Medical Systems (Get Rating)
Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. It offers destruction of arteriosclerotic blockages by laser radiation ablation, a minimally invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. The company sells its products primarily through distributors in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.
Receive News & Ratings for AngioDynamics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for AngioDynamics and related companies with MarketBeat.com’s FREE daily email newsletter.